Asked about the FDA's warning about the use of hydroxychloroquine for coronavirus patients, Trump responded by attacking a non-peer reviewed study released last month that found an increased risk of death associated with patients who were only treated with the antimalarial drug — calling it a "false study."
Why it matters: The president, who revealed Monday he is taking the drug as a "line of defense" against the virus, referred to the study as a "Trump enemy statement." He did not address the FDA's warning that hydroxychloroquine appears to cause some serious and potentially life-threatening side effects in coronavirus patients.
Context: The study in question was not peer reviewed and retrospectively analyzed a very small pool of male veterans, with approval from Veterans Affairs.
- The authors of the study stressed that their limited findings "highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drugs."
What they're saying: "No, that's not what I was told," Trump said in response to a question about the FDA warning. "There was a false study done where they gave it to very sick people, extremely sick people, people that were ready to die. It was given by obviously not friends of the administration, and the study came out, the people were ready to die, everybody was old, had bad problems with hearts, diabetes and everything else you can imagine."
- Veterans Affairs Secretary Robert Wilkie weighed in after and said, "That was not a VA study. Researchers took VA numbers and they did not clinically review them, they were not peer reviewed. They did not even look at what the president just mentioned — the various co-morbidities that the patients who were referenced in that study had."
- He continued: "So I want to knock down the phony story that this is somehow the VA going back on what the president told us to do, which was to use every means possible to protect and preserve the lives of our veterans."